NCT07407933 2026-02-12A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsMediLink Therapeutics (Suzhou) Co., Ltd.Phase 1/2 Not yet recruiting118 enrolled
NCT03899792 2026-01-06LIBRETTO-121Eli Lilly and CompanyPhase 1/2 Active not recruiting36 enrolled 13 charts 2 FDA